BBIO logo

BridgeBio Pharma, Inc. (BBIO) Net income

annual net income:

-$543.35M+$109.90M(+16.82%)
December 31, 2024

Summary

  • As of today (September 13, 2025), BBIO annual net profit is -$543.35 million, with the most recent change of +$109.90 million (+16.82%) on December 31, 2024.
  • During the last 3 years, BBIO annual net income has risen by +$43.11 million (+7.35%).
  • BBIO annual net income is now -1139.61% below its all-time high of -$43.83 million, reached on December 31, 2017.

Performance

BBIO Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

quarterly net income:

-$183.76M-$14.15M(-8.34%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BBIO quarterly net profit is -$183.76 million, with the most recent change of -$14.15 million (-8.34%) on June 30, 2025.
  • Over the past year, BBIO quarterly net income has dropped by -$108.21 million (-143.25%).
  • BBIO quarterly net income is now -7080.85% below its all-time high of -$2.56 million, reached on June 30, 2022.

Performance

BBIO quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

TTM net income:

-$785.01M-$108.21M(-15.99%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BBIO TTM net profit is -$785.01 million, with the most recent change of -$108.21 million (-15.99%) on June 30, 2025.
  • Over the past year, BBIO TTM net income has dropped by -$323.49 million (-70.09%).
  • BBIO TTM net income is now -1750.13% below its all-time high of -$42.43 million, reached on March 31, 2018.

Performance

BBIO TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BBIO Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.8%-143.3%-70.1%
3 y3 years+7.3%-7080.9%-51.8%
5 y5 years-88.3%-34.9%-103.8%

BBIO Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-12.1%+16.8%-7080.9%+31.3%-84.3%at low
5 y5-year-88.3%+16.8%-7080.9%+31.3%-103.8%at low
alltimeall time-1139.6%+16.8%-7080.9%+31.3%-1750.1%at low

BBIO Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$183.76M(+8.3%)
-$785.01M(+16.0%)
Mar 2025
-
-$169.61M(-36.6%)
-$676.79M(+24.6%)
Dec 2024
-$543.35M(-16.8%)
-$267.39M(+62.8%)
-$543.35M(+21.7%)
Sep 2024
-
-$164.25M(+117.4%)
-$446.29M(-3.3%)
Jun 2024
-
-$75.54M(+108.9%)
-$461.52M(-15.6%)
Mar 2024
-
-$36.16M(-78.8%)
-$546.68M(-16.3%)
Dec 2023
-$653.25M(+34.8%)
-$170.33M(-5.1%)
-$653.25M(+4.8%)
Sep 2023
-
-$179.49M(+11.7%)
-$623.49M(+6.7%)
Jun 2023
-
-$160.70M(+12.6%)
-$584.20M(+37.1%)
Mar 2023
-
-$142.73M(+1.5%)
-$426.05M(-12.1%)
Dec 2022
-$484.65M(-17.4%)
-$140.57M(+0.3%)
-$484.65M(-2.4%)
Sep 2022
-
-$140.19M(+5378.4%)
-$496.36M(-4.0%)
Jun 2022
-
-$2.56M(-98.7%)
-$517.19M(-16.1%)
Mar 2022
-
-$201.33M(+32.2%)
-$616.70M(+5.2%)
Dec 2021
-$586.45M
-$152.28M(-5.4%)
-$586.45M(+3.0%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$161.02M(+57.7%)
-$569.20M(+5.7%)
Jun 2021
-
-$102.07M(-40.3%)
-$538.35M(-6.0%)
Mar 2021
-
-$171.08M(+26.7%)
-$572.49M(+13.3%)
Dec 2020
-$505.49M(+75.2%)
-$135.03M(+3.7%)
-$505.49M(+11.2%)
Sep 2020
-
-$130.17M(-4.4%)
-$454.61M(+18.0%)
Jun 2020
-
-$136.21M(+30.9%)
-$385.11M(+19.1%)
Mar 2020
-
-$104.08M(+23.7%)
-$323.23M(+12.0%)
Dec 2019
-$288.58M(+70.3%)
-$84.15M(+38.7%)
-$288.58M(+41.2%)
Sep 2019
-
-$60.66M(-18.4%)
-$204.43M(+10.0%)
Jun 2019
-
-$74.33M(+7.1%)
-$185.85M(+26.2%)
Mar 2019
-
-$69.44M(+65.0%)
-$147.22M(+22.5%)
Dec 2018
-$169.45M(+286.6%)
-
-
Sep 2018
-
-$42.08M(+17.9%)
-$120.21M(+53.9%)
Jun 2018
-
-$35.70M(-15.9%)
-$78.13M(+84.1%)
Mar 2018
-
-$42.43M
-$42.43M
Dec 2017
-$43.83M
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual net profit?
  • What is the all time high annual net income for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual net income year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly net profit?
  • What is the all time high quarterly net income for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly net income year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM net profit?
  • What is the all time high TTM net income for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM net income year-on-year change?

What is BridgeBio Pharma, Inc. annual net profit?

The current annual net income of BBIO is -$543.35M

What is the all time high annual net income for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual net profit is -$43.83M

What is BridgeBio Pharma, Inc. annual net income year-on-year change?

Over the past year, BBIO annual net profit has changed by +$109.90M (+16.82%)

What is BridgeBio Pharma, Inc. quarterly net profit?

The current quarterly net income of BBIO is -$183.76M

What is the all time high quarterly net income for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly net profit is -$2.56M

What is BridgeBio Pharma, Inc. quarterly net income year-on-year change?

Over the past year, BBIO quarterly net profit has changed by -$108.21M (-143.25%)

What is BridgeBio Pharma, Inc. TTM net profit?

The current TTM net income of BBIO is -$785.01M

What is the all time high TTM net income for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM net profit is -$42.43M

What is BridgeBio Pharma, Inc. TTM net income year-on-year change?

Over the past year, BBIO TTM net profit has changed by -$323.49M (-70.09%)
On this page